These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 28498774)

  • 41. Direct-to-Consumer Genetic Testing: The Implications of the US FDA's First Marketing Authorization for BRCA Mutation Testing.
    Gill J; Obley AJ; Prasad V
    JAMA; 2018 Jun; 319(23):2377-2378. PubMed ID: 29800087
    [No Abstract]   [Full Text] [Related]  

  • 42. Black-box warning: direct-to-consumer marketing.
    Lancet Oncology
    Lancet Oncol; 2014 Jan; 15(1):1. PubMed ID: 24384487
    [No Abstract]   [Full Text] [Related]  

  • 43. 23andMe: a new two-sided data-banking market model.
    Stoeklé HC; Mamzer-Bruneel MF; Vogt G; Hervé C
    BMC Med Ethics; 2016 Mar; 17():19. PubMed ID: 27059184
    [TBL] [Abstract][Full Text] [Related]  

  • 44. DTC genetic services: a look across the pond.
    Borry P; Howard H
    Am J Bioeth; 2008 Jun; 8(6):14-6. PubMed ID: 18726773
    [No Abstract]   [Full Text] [Related]  

  • 45. Response to Open Peer Commentaries on "Ethical Dimensions of Direct-to-Consumer Neurotechnologies".
    Kreitmair KV
    AJOB Neurosci; 2019; 10(4):W1-W3. PubMed ID: 31663829
    [No Abstract]   [Full Text] [Related]  

  • 46. Digital health - a new medical cosmology? The case of 23andMe online genetic testing platform.
    Saukko P
    Sociol Health Illn; 2018 Nov; 40(8):1312-1326. PubMed ID: 29998537
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Direct-to-consumer genomics and research ethics: should a more robust informed consent process be included?
    Wasson K
    Am J Bioeth; 2009; 9(6-7):56-8. PubMed ID: 19998119
    [No Abstract]   [Full Text] [Related]  

  • 48. Should medical device representatives assist surgeons?
    Pollner F; O'Connor B; Fugh-Berman A
    J Eval Clin Pract; 2019 Dec; 25(6):977-979. PubMed ID: 30623529
    [No Abstract]   [Full Text] [Related]  

  • 49. Correction of misleading information in prescription drug television advertising: The roles of advertisement similarity and time delay.
    Aikin KJ; Southwell BG; Paquin RS; Rupert DJ; O'Donoghue AC; Betts KR; Lee PK
    Res Social Adm Pharm; 2017; 13(2):378-388. PubMed ID: 27178746
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Direct-to-Consumer Drug Advertising in Oncology Is Not Beneficial to Patients or Public Health.
    Schnipper LE; Abel GA
    JAMA Oncol; 2016 Nov; 2(11):1397-1398. PubMed ID: 27532895
    [No Abstract]   [Full Text] [Related]  

  • 51. Perceptions of Direct-to-Consumer Advertising and the Older Adult Population.
    Bailey TA; Fenney M
    Consult Pharm; 2016 Apr; 31(4):215-20. PubMed ID: 27056358
    [TBL] [Abstract][Full Text] [Related]  

  • 52. "If You See Something, Say Something".
    Sweet DJ
    Cell Stem Cell; 2016 Aug; 19(2):139-140. PubMed ID: 27494665
    [No Abstract]   [Full Text] [Related]  

  • 53. To ban or not to ban? Clinical geneticists' views on the regulation of direct-to-consumer genetic testing.
    Howard HC; Borry P
    EMBO Rep; 2012 Sep; 13(9):791-4. PubMed ID: 22890467
    [No Abstract]   [Full Text] [Related]  

  • 54. High Stakes: Direct to Consumer Marketing of Unproven Stem Cell Treatments for Lung Disease.
    Glassberg MK; Csete IS; Toonkel RL
    Chest; 2018 Jun; 153(6):1294-1295. PubMed ID: 29884248
    [No Abstract]   [Full Text] [Related]  

  • 55. [Direct-to-consumer genetic testing through Internet: marketing, ethical and social issues].
    Ducournau P; Gourraud PA; Rial-Sebbag E; Bulle A; Cambon-Thomsen A
    Med Sci (Paris); 2011 Jan; 27(1):95-102. PubMed ID: 21299969
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risks and benefits of direct-to-consumer genetic testing remain unclear.
    Kuehn BM
    JAMA; 2008 Oct; 300(13):1503-5. PubMed ID: 18827199
    [No Abstract]   [Full Text] [Related]  

  • 57. Direct-to-Consumer Drug Company Pharmacies.
    Rome BN
    JAMA; 2024 Mar; 331(12):1003-1004. PubMed ID: 38412063
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Direct-to-consumer marketing for genetic testing.
    Theology and Ethics Department, Catholic Health Association
    Health Prog; 2003; 84(5):35-6, 50. PubMed ID: 14513756
    [No Abstract]   [Full Text] [Related]  

  • 59. Genetic profiteering.
    De Francesco L
    Nat Biotechnol; 2006 Aug; 24(8):888-90. PubMed ID: 16900119
    [No Abstract]   [Full Text] [Related]  

  • 60. Direct-to-Consumer Marketing: The Ethics of Snake Oil Sales?
    Foster TE
    Am J Sports Med; 2023 Apr; 51(5):1133-1135. PubMed ID: 37002724
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.